Search

everythinglearnresearchcommunity

for

Search:↓

The oral testosterone effectively increased testosterone levels and reduced SHBG, showing promise for treating testosterone deficiency.

Testosterone increases hair testosterone levels, stress raises hair cortisol, and relationship status affects hormone levels.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

The market for these drugs is expected to grow.

The compounds tested could potentially treat hair loss and alopecia.

Dihydrotestosterone (DHT) worsens heart enlargement, and blocking it may help prevent heart issues.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Dutasteride and finasteride can change semen and hormone levels in men.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Finasteride's metabolites were identified, helping understand how the drug is processed in the body.

5alpha-reductase 2 is crucial for proper male brain development and sexual differentiation.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

Women with hair thinning have disrupted steroid hormone levels, but this doesn't often show as other health issues. More research is needed on hormone balance in this condition.

Dutasteride effectively and safely treats male hair loss for over a year.

Finasteride reduces hair growth and is safe for women with excessive hair.

Dihydrotestosterone makes arteries stiffer in female mice by reducing estrogen receptor expression.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Doping in football faces legal challenges with testosterone limits, hair loss treatments, and recreational drug use.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Testosterone therapy improves strength and body composition in older men with low testosterone.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.